--- a
+++ b/clusters/9knumclustersv2/clust_153.txt
@@ -0,0 +1,190 @@
+Creatinine clearance >=  ml/min documented within  days prior to step  registration
+Calculated (calc.) creatinine clearance >=  mL/min\r\n* Estimated creatinine clearance for patients >=  years old will be estimated by the Jelliffe equation modified for body surface area (BSA); patients with creatinine clearance estimated > ml/min by this formula are eligible; if the creatinine clearance estimated by the Jelliffe method is >=  mL/min but =<  mL/min, then a second method to confirm a creatinine clearance of >=  mL/min is required; methods of estimating glomerular filtration rate (GFR) that can be used for this confirmation consist of a  or -hour urine creatinine clearance or a nuclear creatinine clearance test; if the confirmatory creatinine clearance is <  mL/min, then the patient is not eligible; if the confirmatory creatinine clearance is >=  mL/min, the patient is eligible; if the cause of the patients renal dysfunction is tumor obstructing the ureters, then eligibility can be determined by the study chair even if it does not meet these minimal requirements; for patients <  years old, it is strongly suggested that a radioisotope estimation of GFR be obtained; if a radioisotope test is not possible, an estimated creatinine clearance using either a  or  hour urine creatinine clearance or the Schwartz formula can be used; patients will be considered eligible if the creatinine clearance is >  mL/min; if the creatinine clearance estimated by the Schwartz formula or urine creatinine clearance is >=  mL/min but =<  mL/min, then a second method to confirm a creatinine clearance of >=  mL/min is required; methods of estimating GFR that can be used for this confirmation consist of a - or -hour urine creatinine clearance if the Schwartz formula or radioisotope method was used as the primary method or a radioisotope estimation of GFR if the Schwartz formula or urine creatinine clearance method was used as the primary method; if the confirmatory creatinine clearance is <  mL/min, then the patient is not eligible; if the confirmatory creatinine clearance is >=  mL/min, the patient is eligible
+Serum creatinine clearance >=  ml/min
+Creatinine clearance >=  mL/min
+ELIGIBILITY CRITERIA - PHASE I (ARMS A, B, C): Creatinine clearance of at least  mL/min within  days prior to first dose of study agent
+ELIGIBILITY CRITERIA - PHASE II (ARM D): Creatinine clearance of at least  mL/min within  days prior to first dose of study agent
+Creatinine clearance <  mL/min
+Creatinine clearance > mL/min
+Creatinine clearance =<  mL/min
+Creatinine clearance ?  mL/min (see Section .. for instructions regarding calculation of creatinine clearance) performed within  days prior to randomization.
+Obtained =<  weeks prior to registration: Creatinine clearance >=  mL/min
+Creatinine clearance >=  mL/min/. m^
+Creatinine clearance ?  mL/min
+Serum creatinine clearance >=  mL/min (performed within  days of treatment initiation)
+Creatinine clearance >=  mL/min/. m^
+Estimated creatinine clearance >=  ml/min
+Creatinine within  times normal institutional limits OR creatinine clearance >=  mL/min/. m^; Note, dose adjustments are required for creatinine clearance (CrCl) >=  mL/min but =<  ml/min
+Creatinine clearance ? mL/min
+Creatinine =< . or creatinine clearance >=  ml/ml
+Creatinine clearance >=  mL/min
+Estimated creatinine clearance must be >  mL/min
+Creatinine clearance <  ml/min
+Creatinine clearance >  mL/min
+Creatinine clearance >=  mL/min
+Creatinine clearance >=  ml/min
+Obtained within  days prior to cycle , day : serum creatinine clearance >= ml/min
+Creatinine: Creatinine clearance >  ml/min
+Creatinine clearance - mL/min
+Creatinine clearance ?  mL/min
+Creatinine clearance >  ml/min
+Creatinine clearance >=  mL/min
+Creatinine clearance ? ml/min
+Creatinine clearance of >=  mL/min
+Creatinine clearance <  ml/min
+Creatinine clearance >=  ml/min
+Within  days before the first dose of study drug: creatinine clearance >  mL/min
+Creatinine clearance >=  mL/min.
+Subjects with severe renal impairment (i.e., creatinine clearance =<  mL/min)
+Creatinine clearance >=  mL/min/. m^
+Creatinine clearance >=  mL/min/. m^
+For Arm G, subjects must have an estimated creatinine clearance >=  ml/min.
+Serum creatinine clearance >=  mL/min
+Creatinine clearance >=  mL/min/. m^ unless reduced creatinine clearance felt by investigator to be acute and reversible
+Measured creatinine clearance >  mls/min
+Creatinine clearance <  ml/min
+Creatinine clearance >=  ml/min
+Serum creatinine clearance >=  mL/min
+Creatinine clearance ?  ml/min
+Cabazitaxel: Creatinine clearance >=  mL/min/. m^
+Creatinine clearance of >=  ml/min
+Creatinine clearance >=  mL/min
+Estimated creatinine clearance >=mL/min/. square meter (m^)
+Serum creatinine ? . x ULN or calculated creatinine clearance ?  mL/min based on the Cockroft-Gault GFR estimation. For newly diagnosed AML patients <  years of age, creatinine clearance ?  mL/min; for ?  years of age, creatinine clearance ?  mL/min.
+Estimated creatinine clearance >  ml/min
+Estimated creatinine clearance >  mL/min (this must be checked twice before initiating therapy)
+Creatinine clearance <  mL/min
+Creatinine clearance >  ml/min
+Estimated or measured creatinine clearance >  mL/min
+Creatinine clearance greater than  ml/min
+Serum creatinine clearance >=  ml/min
+Creatinine clearance >= to  ml/min
+Creatinine clearance <  ml/min which cannot be attributed to MCC metastasis
+Creatinine clearance of >=  mL/min
+Serum creatinine =< . or estimated creatinine clearance >=  ml/min and not dialysis-dependent
+Creatinine (Cr) clearance >=  mL/min
+Creatinine clearance >=  mL/min
+Estimated creatinine clearance must be >  mL/min
+Creatinine clearance of <  ml/min
+Estimated creatinine clearance <  mL/min
+Creatinine clearance >=  mL/minutes
+Creatinine clearance (Clcr) >  mL/min
+Creatinine clearance <  ml/min
+Estimated creatinine clearance >=  mL/min
+Creatinine clearance >=  mL/min/. m^
+Creatinine clearance <  mL/min/.m^
+Estimated creatinine clearance at least  ml/min
+Creatinine clearance >  ml/min/. m^ (Schwartz formula)
+Relapsed/refractory MCL: Creatinine (Cr) clearance >=  mL/min
+Newly diagnosed MCL: Creatinine (Cr) Clearance >=  mL/min
+Creatinine clearance >=  ml/min/.m^
+Creatinine clearance of >=  mL/min
+Creatinine clearance equal to or more than  mL/min
+Creatinine clearance of >=  mL/min
+Creatinine clearance of >=  ml/min
+Creatinine clearance >  ml/min
+Patients with renal insufficiency or creatinine (cr) clearance <  ml/min
+Creatinine =< . or creatinine clearance >=  ml/min
+Estimated creatinine clearance >=  ml/min
+All adults with a creatinine > . or a history of renal dysfunction must have estimated creatinine clearance >  ml/min
+Creatine clearance >=  ml/min
+Creatinine < . (adults) or creatinine clearance >  ml/min (pediatrics)
+Creatinine clearance >=  mL/min (repeat if more than  days before the first dose)
+Creatinine clearance ?  mL/min
+Within  days prior to first dose of study drug treatment: Creatinine clearance >=  mL/min
+Creatinine clearance >=  mL/min/. m^
+Creatinine clearance >=  mL/min/. m^
+Creatinine clearance >=  mL/min
+Within  days prior to administration of therapy: Creatinine clearance >=  mL/min
+Creatinine clearance <  ml/min
+Creatinine clearance >=  mL/min/. m^
+Patient with severe renal disease (i.e. creatinine greater than  times normal for age; creatinine clearance less than  ml/min/.m^)
+Creatinine clearance >=  mL/min, unless secondary to renal involvement by lymphoma; for creatinine clearance <  mL/min due to kidney involvement by tumor
+Creatinine clearance within  weeks of registration must be at least  ml/min
+Estimated creatinine clearance ?  mL/min.
+Creatinine clearance  to  mL/min.
+Estimated creatinine clearance ?  mL/min.
+Estimated Creatinine Clearance ? mL/min
+Creatinine clearance >=  mL/min
+Creatinine clearance or estimated GFR .  mL/min/.m
+Renal: Creatinine clearance ?mL/min;
+Creatinine clearance inferior to  mL per min (MDRD Formula).
+Estimated Creatinine Clearance ? mL/min
+For patients who have creatinine clearance that meets >  ml/min they must not have received prior systemic doxorubicin
+Creatinine clearance >  ml/min
+Creatinine clearance >=  mL/min
+Measured creatinine clearance >  ml/min or estimated creatinine clearance >  ml/min
+Creatinine clearance >=  mL/min
+Estimated creatinine clearance >= ml/min
+Creatinine clearance >=  mL/min
+Renal: Estimated or measured creatinine clearance >=  mL/min.
+Subject has severe renal impairment (creatinine clearance <  ml/min).
+Creatinine clearance >=  mL/min
+Creatinine (Cr) clearance >=  mL/min
+Creatinine clearance >  ml/min
+Creatinine clearance <  mL/min
+Creatinine clearance of >=  ml/min
+Creatinine clearance >=  mL/min
+Creatinine clearance ? mL/min
+Creatinine (Cr) clearance >=  mL/min
+Estimated creatinine clearance of >=  ml/min
+Creatinine Clearance of ?  mL/min
+Creatinine clearance: the standard Cockcroft and Gault formula must be used to calculate creatinine clearance (CrCl) for enrollment or dosing; also include in the pre-treatment or baseline text portion of the protocol, the 'On Study Evaluations or During Treatment' for every pemetrexed treatment day, and also capture in the study Schedule of Events; no dosage adjustment is needed in patients with creatinine clearance >  mL/min; insufficient numbers of patients have been studied with creatinine clearance <  mL/min to give a dose recommendation; therefore, pemetrexed should not be administered to patients whose creatinine clearance is <  mL/min
+Creatinine clearance >=  mL/min
+creatinine clearance of <  mL/min
+Creatinine clearance of >  ml/min
+Estimated creatinine clearance <  ml/min
+Renal insufficiency of creatinine clearance <mL/min
+Creatinine clearance estimated to be >=  ml/min
+Creatinine clearance <  ml/min
+Creatinine clearance (Clcr) >  mL/min
+Creatinine clearance >=  ml/min
+creatinine clearance <  mL/min, or
+Estimated creatinine clearance (CLcr) >  ml/min
+Creatinine clearance of >=  ml/min
+Creatinine clearance >=  ml/mm
+Renal clearance CCR <  mL/min
+Creatinine clearance >=  ml/min
+Creatinine clearance >  mL/min
+Creatinine clearance >=  mL/min
+Creatinine Clearance ?  ml/min
+Creatinine clearance <  ml/min which cannot be attributed to MCC metastasis
+Patients with creatinine clearance: <  mL/min are excluded from this protocol; capecitabine is contraindicated in severe renal impairment (clearance <  mL/min)
+Creatinine clearance ?  mL/min
+Creatinine clearance >  ml/min
+Creatinine clearance must be > ml/min
+Creatinine clearance >= mL/min
+Creatinine clearance >=  ml/min
+Severe renal impairment (creatinine clearance =<  ml/min)
+Creatinine clearance ?  mL/min
+Creatinine clearance >  ml/min
+Estimated creatinine clearance of ? mL/min
+Creatinine clearance >=  mL/min
+Measured creatinine clearance >=  mL/min
+Creatinine clearance >=  mL/min
+Creatinine Clearance <  mL/min
+Subjects with creatinine clearance ? mL/min who are not being treated with continuous renal replacement therapy (CRRT).
+Total Cumulative Illness Rating Scale (CIRS) >  and/or creatinine clearance <  ml/min
+Estimated serum creatinine clearance >  ml/min
+Creatinine clearance of >  ml/min/.m^
+Creatinine clearance >=  mL/min
+Creatinine clearance >=  mL/min
+Patients with a creatinine clearance of <  ml/min
+Moderate to severe renal failure (creatinine clearance [Clcr] <  mL/min)
+Patients with a creatinine clearance <  mL/min
+Measured creatinine clearance more than  mL/min; the updated Schwartz formula should be used for pediatric patients (>=  to  years old)
+Creatinine clearance >=  ml/min
+Estimated creatinine clearance ? ml/min
+Creatinine clearance >=  mL/min
+Estimated creatinine clearance >=  ml/min
+Patients with creatinine clearance of less than or equal to  ml/min
+Creatinine clearance ?  mL/min
+Creatinine =< ., or creatinine clearance >=  mL/min
+known renal insufficiency with estimated creatinine clearance (eGRF) of less than  mL/min;
+Measured creatinine clearance more than  mL/min; the updated Schwartz formula should be used for pediatric patients (>=  to  years old)
+Estimated creatinine clearance >=  ml/min
+Significant renal disease as defined by creatinine clearance less than  mL/min
+Creatinine clearance >=  mL/min
+Estimated serum creatinine clearance of ?  mL/min
+Severe renal impairment (i.e. creatinine clearance <  mL/min)
+Estimated creatinine clearance <  mL/min